Status:
COMPLETED
The Effect of Cetirizine on Bronchoconstriction
Lead Sponsor:
New York City Health and Hospitals Corporation
Conditions:
Allergic Rhinitis
Asthma
Eligibility:
All Genders
6-20 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine the effect of cetirizine, an oral antihistamine, on wheezing in patients with allergic rhinitis. Patients presenting to the pediatric emergency department who...
Detailed Description
This is a prospective randomized, placebo-controlled trial to look at the effect of cetirizine on bronchoconstriction in patients with allergic rhinitis who present to the Pediatric Emergency Departme...
Eligibility Criteria
Inclusion
- History of allergic rhinitis
- Wheezing
Exclusion
- Use of antihistamine within the past 72 hours
- Chronic Pulmonary Condition other than asthma
- Other contraindication to cetirizine
- Severe asthma exacerbation requiring resuscitation
Key Trial Info
Start Date :
May 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03340740
Start Date
May 11 2018
End Date
August 30 2021
Last Update
October 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jacobi Medical Center
The Bronx, New York, United States, 10461